Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
SUTRO BIOPHARMA, INC. | CHIEF MEDICAL OFFICER | Common Stock | 97.5K | $104K | $1.07 | May 1, 2025 | Direct |
SUTRO BIOPHARMA, INC. | CHIEF MEDICAL OFFICER | Restricted Stock Unit (RSU) | 17.8K | $90.8K | $2.69 | May 1, 2025 | Direct |
CURIS INC | Director | Non Qualified Stock Option | 14.4K | $45.1K | $3.13 | May 20, 2025 | Direct |
NextCure, Inc. | Director | Stock Option (Right to Buy) | 18.7K | Jun 20, 2025 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
NXTC | NextCure, Inc. | Jun 20, 2025 | 1 | $0 | 4 | Jun 24, 2025 | Director |
CRIS | CURIS INC | May 20, 2025 | 1 | $45.1K | 4 | May 22, 2025 | Director |
STRO | SUTRO BIOPHARMA, INC. | May 1, 2025 | 5 | -$26.4K | 4 | May 5, 2025 | CHIEF MEDICAL OFFICER |
STRO | SUTRO BIOPHARMA, INC. | Feb 28, 2025 | 6 | -$31.8K | 4 | Mar 4, 2025 | CHIEF MEDICAL OFFICER |
CRIS | CURIS INC | Jan 28, 2025 | 1 | $5.01K | 4 | Jan 30, 2025 | Director |
NXTC | NextCure, Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 21, 2024 | Director |
CRIS | CURIS INC | May 21, 2024 | 1 | $49.4K | 4 | May 23, 2024 | Director |
STRO | SUTRO BIOPHARMA, INC. | Mar 5, 2024 | 2 | $0 | 4 | Mar 7, 2024 | CHIEF MEDICAL OFFICER |
STRO | SUTRO BIOPHARMA, INC. | Feb 29, 2024 | 3 | -$64.4K | 4 | Mar 4, 2024 | CHIEF MEDICAL OFFICER |
NXTC | NextCure, Inc. | Jun 22, 2023 | 1 | $0 | 4 | Jun 23, 2023 | Director |
STRO | SUTRO BIOPHARMA, INC. | Mar 15, 2023 | 2 | $0 | 4 | Mar 17, 2023 | Chief Medical Officer |
STRO | SUTRO BIOPHARMA, INC. | Feb 28, 2023 | 0 | $0 | 3 | Mar 7, 2023 | Chief Medical Officer |
CRIS | CURIS INC | Jan 23, 2023 | 1 | $0 | 4 | Jan 24, 2023 | Director |
CRIS | CURIS INC | Oct 12, 2022 | 1 | $0 | 4 | Oct 14, 2022 | Director |
CRIS | CURIS INC | Oct 12, 2022 | 0 | $0 | 3 | Oct 14, 2022 | Director |
NXTC | NextCure, Inc. | Jun 23, 2022 | 1 | $0 | 4 | Jun 24, 2022 | Director |
NXTC | NextCure, Inc. | Oct 1, 2021 | 2 | $0 | 4 | Oct 5, 2021 | Director |
NXTC | NextCure, Inc. | Oct 1, 2021 | 0 | $0 | 3 | Oct 5, 2021 | Director |